Sitemap
- Cookie Policy - Cookie Policy
- Terms of Use - Terms of Use
- Email & Phone subscription PDPN
-
My Account
-
Science
-
Cutting Edge Science
-
Cardiovascular
-
Thrombosis
- Assessment of predictors for cancer-associated VTE recurrence after discontinuation of anticoagulant therapy: A multicenter cohort study
- Rethinking CAT Management: From Evidence to Expert Guidance
- Unmasking the Hidden Threat: VTE in Lung Cancer
- Latest Insights in Managing Venous Thromboembolism in Cancer Care
- Insights into Enoxaparin Therapy for High-Risk Patients
- Management of Anticoagulant-Related Bleeding in VTE
- Unveiling the Timeline: Major Surgery, VTE Events, and Prolonged LMWH Use
- Navigating Complexities in Anticoagulation: Insights for Optimal Management
- From Risk Scores to Better Survival: Navigating the Future of Pulmonary Embolism Management
- From Risk to Recurrence: Clinical Truths from the RIETE Registry on VTE Outcomes
- Anti-coagulant treatment of cancer-associated thrombosis in frail patients
- Cancer-Associated VTE: Balancing Recurrence, Bleeding, and Clinical Risk
- Awareness of venous thromboembolism among patients with cancer: Preliminary findings from a global initiative for world thrombosis day
- Dyslipidemia
-
Acute coronary syndrome
- Charting the Course of Antiplatelet Therapy in Elderly ACS Patients
- Exploring Dual Antiplatelet Therapy Approaches in Acute Coronary Syndrome
- Evolving strategies in CAD Management
- Crossroads of Cardiovascular Care: Insights into PCI and AMI Treatment Strategies
- Optimizing Treatment Strategies in Acute Coronary Syndrome
- Enhancing Antiplatelet Therapy for Older Patients: Balancing Risks and Benefits
- De-Escalation Strategies, Gender Differences, and Monotherapy Efficacy
- Antiplatelet Therapy and Statin Strategies in ACS: A Deep Dive into Efficacy and Safety
- Advances in Antiplatelet Therapy: Improving Outcomes with Tailored Approaches
- Refining Dual Antiplatelet Therapy: Latest Evidence for Stroke and ACS
- ACS Management: Insights on Rare Cases and Emerging Predictors
- Clopidogrel: Rethinking Antiplatelet Strategies for Better Outcomes
- Optimizing Hypertension Management: Single-Pill Combinations and Key Insights for Better Outcomes
- Evolving Insights on DAPT and SAPT: Highlights From Recent Key Trials
- Dual Therapy, FCAPs, and Antiplatelets: Recent Evidence You Should Know
-
Thrombosis
-
Diabetes
- Exploring Gla-300 use in individuals with renal impairment
- Find your answer to help adults with insufficiently controlled T2D get to target HbA1c2-6
- Discover outcomes seen after starting Gla-300 in people with inadequately controlled T2DM on prior GLP-1 RA
- FRC vs Premix insulin: Key Study Findings
- Early Detection Transforming Type 1 Diabetes Care in Children
- Empowering Diabetes Care: Cutting-Edge Technology and Patient-Focused Innovations
- Optimizing T2DM Management: Unlocking New Possibilities
- Critical Insights into Hypoglycemia and Diabetes Management
- Diabetes in Asians: Tailoring Management to Unique Metabolic Profiles
- Optimizing Diabetes Management: Insights on Therapeutic Use of the Fixed-Ratio Combination
- Managing Diabetes: Exploring Optimal Treatment Approaches
- Role of Biomarkers & Personalized Care in Diabetes Management
- Dive into diabetes management and basal insulin excellence secrets.
- Treatment advancement with basal insulin in people with T2D on prior GLP-1 RA therapy
- Exploring the Significance of Time in Range (TIR) for Glycemic Management
- The impact of early hypoglycemia
- Unlocking Insights in Diabetes Management during Ramadan
- Harnessing Technology for Better Outcomes in Diabetes Care
- Explore the importance of Time-in-range (TIR) and glycemic variability (GV)
-
Vaccines
-
Childhood
- Prescribe with simplify schedule by choosing hexavalent Vaccine
- Vaccine Effectiveness against Pediatric Influenza-a-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022-2023 Season, Vision Network
- Influenza Vaccination in Children with Pulmonary Disease During the Covid-19 Pandemic
- Inpatient Burden of Respiratory Syncytial Virus in Children ≤2 Years of Age in Germany: A Retrospective Analysis of Nationwide Hospitalization Data, 2019-2022
- Inpatient Burden of Respiratory Syncytial Virus in Children ≤2 Years of Age in Germany: A Retrospective Analysis of Nationwide Hospitalization Data, 2019-2022
- Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease in Children. Statement of the Spanish Society of Paediatric Infectious Disease (Seip)
- Effectiveness of Poliovirus Vaccines against Circulating Vaccine-Derived Type 2 Poliomyelitis in Nigeria between 2017 and 2022: A Case-Control Study
- Risk Factors for Severe Respiratory Syncytial Virus Infection in Hospitalized Children
- Cost-Effectiveness of Seasonal Influenza Vaccination of Children in China: A Modeling Analysis
- The Impact of Rsv Hospitalization on Children's Quality of Life
- Persistence of Antibodies 5 Years after Hepatitis B Vaccination in Preterm Birth Children: A Retrospective Cohort Study Using Real-World Data
- Uncovering the Burden of Influenza in Children in Portugal, 2008-2018
- Seroprevalence of Hepatitis A Virus Antibodies among Children and Adolescents Living in Northern Thailand: An Implication for Hepatitis A Immunization
- Influenza Vaccine Effectiveness among Children: 2011-2020
- Nirsevimab for Prevention of Hospitalizations Due to Rsv in Infants
- What is the benefit of the acP vaccine?
- Choose aP vaccinesto improve parent's satisfaction
- Effectiveness of Poliovirus Vaccines against Circulating Vaccine-Derived Type 2 Poliomyelitis in Nigeria between 2017 and 2022: A Case-Control Study
- Health care professionals’ preference for a fully liquid, ready-to-use hexavalent vaccine in Spain
- Thai Clinical Practice Guideline for the use of Nirsevimab
-
General
- Real-World Impact and Effectiveness of Menacwy-Tt
- Structured Benefit-Risk Assessment of a New Quadrivalent Meningococcal Conjugate Vaccine (Menacyw-Tt) in Individuals Ages 12 Months and Older
- Meningococcal Disease in the Post-Covid-19 Era: A Time to Prepare
- Health care professionals' preference for a fully liquid, ready-to-use hexavalent vaccine in Spain
- Cost-Minimization and Budget Impact Analysis of a Hexavalent Vaccine in the Colombian Expanded Program on Immunization
-
Influenza
- Cost-Effectiveness of Influenza Vaccination with a High Dose Quadrivalent Vaccine of the Elderly Population in Belgium, Finland, and Portugal
- Global Burden of Influenza Lower Respiratory Tract Infections in Older People from 1990 to 2019
- Cost-Effectiveness of High-Dose Quadrivalent Influenza Vaccine Versus Standard-Dose Quadrivalent Influenza Vaccine for Older People in a Country with High Influenza Vaccination Rate
- Influenza Vaccination for Elderly, Vulnerable and High-Risk Subjects: A Narrative Review and Expert Opinion
- Estimated Health and Economic Impact of Using High-Dose Influenza Vaccine on Respiratory and Circulatory Plus Respiratory Hospitalizations of Older Adults in Australia
- Effectiveness of Influenza Vaccination against Coronavirus Disease (Covid)-19 Outcomes in Hospitalized Individuals in Brazil: An Epidemiological Study
- Dialysis Patients Respond Adequately to Influenza Vaccination Irrespective of Dialysis Modality and Chronic Inflammation
- Influenza Vaccination and Major Cardiovascular Risk: A Systematic Review and Meta-Analysis of Clinical Trials Studies
- Smoking Cessation and Influenza Vaccination Can Reduce the Healthcare Burden of Copd
- Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort Study
- Cardiologists' Knowledge and Perceptions of the Seasonal Influenza Immunisation
- Cardioprotective Effects of Influenza Vaccine
- Influenza Vaccination in Older Adults and Patients with Chronic Disorders: A Position Paper from the Portuguese Society of Pulmonology, the Portuguese Society of Diabetology, the Portuguese Society of Cardiology, the Portuguese Society of Geriatrics and Gerontology, the Study Group of Geriatrics of the Portuguese Society of Internal Medicine, and the Portuguese Society of Infectious Diseases and Clinical Microbiology
- Immunogenicity and Reactogenicity of Coadministration of Covid-19 and Influenza Vaccines
- Effectiveness of High-Dose Vs. Standard-Dose Quadrivalent Influenza Vaccine against Recurrent Hospitalisations and Mortality in Relation to Influenza Circulation: A Post-Hoc Analysis of the Danflu-1 Randomised Clinical Trial
- Impact of Influenza Vaccination History in the Clinical Course of Older Adults Hospitalized with Covid-19
- Rates of Severe Influenza-Associated Outcomes among Older Adults Living with Diabetes-Influenza Hospitalization Surveillance Network (Flusurv-Net), 2012- 2017
- Efficacy and Prolonged Safety of Haemophilus Influenzae Type B Conjugate Vaccines
- Effect of influenza on outcomes in patients with heart failure.
- WHO recommended composition of influenza virus vaccines for use in 2024-2025 northern hemisphere
- Summary of the National Advisory Committee on Immunization (Naci) Statement-Recommendation on Repeated Seasonal Influenza Vaccination
- Influenza Vaccine Effect on Risk of Stroke Occurrence: A Systematic Review and Meta-Analysis
- Flu Vaccine and Mortality in Hypertension: A Nationwide Cohort Study
- Burden of Influenza Hospitalization among High-Risk Groups in the United States
- Immunogenicity and Safety of High-Dose Quadrivalent Influenza Vaccine in Older Adults in Taiwan: A Phase Iii, Randomized, Multi-Center Study
- Enhanced Passive Safety Surveillance of High-Dose and Standard-Dose Quadrivalent Inactivated Split-Virion Influenza Vaccines in Germany and Finland During the Influenza Season 2021/22
- Burden of Influenza Hospitalization among High-Risk Groups in the United States
- Safeguard your whole family Standard dose for child & adult & High-dose vaccine for seniors 65+
-
Pregnancy
- Effectiveness of Maternal Influenza Vaccination During Pregnancy against Laboratory-Confirmed Seasonal Influenza among Infants under 6 Months of Age in Ontario, Canada
- Safety of Influenza Vaccination During Pregnancy: A Systematic Review
- The Current State of Pertussis Vaccination in Pregnancy around the World, with Recommendations for Improved Care: Consensus Statements from the Global Pertussis Initiative
-
Childhood
- Rare Diseases
-
Cardiovascular
-
Take a break
-
VacciCast
- ประสิทธิภาพป้องกัน admit ของวัคซีนไข้หวัดใหญ่ 4 สายพันธุ์
- ไข้หวัดใหญ่ในผุ้ป่วยเบาหวาน ป้องกันได้ แค่ฉีดวัคซีน
- คลายความสงสัย! ฉีดวัคซีนไข้หวัดใหญ่ไม่ตรงสายพันธุ์ ลดโอกาศติดเชื้อรุนแรงได้?
- Influenza and cardiovascular event
- Best time to vaccinate against influenza
- Influenza vaccination in diabetes patient
- FAQ Frequently ask questions about influenza vaccination
- Fully Liquid Hexavalent Vaccine
- วัคซีน MCVs… ป้องกันโรคไข้กาฬหลังแอ่น
- ผู้ปกครองควรรู้ วัคซีนรวมดีอย่างไร?
- แตกต่างแต่เกี่ยวข้องกัน โรคไข้หวัดใหญ่ส่งผลอย่างไร ต่อโรคหลอดเลือดหัวใจ
- Sequential Polio vaccine regimen
- Combination Vaccine – Values of aP Vaccine
- ฉีดวัคซีนป้องกันโรคไข้กาฬหลังแอ่น
- Influenza Vaccine Masterclass 2024
- ความปลอดภัยของ วัคซีนไข้หวัดใหญ่ชนิด High Dose
- วัคซีนไข้หวัดใหญ่ ตอบชัดทุกประเด็นในคลิปเดียว
-
VacciCast
-
Events
-
Upcoming Events
-
Past Events
- Diabetes
- Cardiovascular
-
Vaccines
- Ready to Use Hexavalent Vaccine – A Decade of Confident in Childhood Prevention
- Influenza Vaccine Masterclass 2024
- Ready to Use Haxavalent Vaccine: A Decade of Confident in Childhood Prevention
- Impact of flu in adult patient and the legend of flu vaccines
- The Importance of Flu Vaccination and Effective Communication
- Immunology
-
Upcoming Events
-
Cutting Edge Science
- Patient Support
- Disclaimer
- Error 404
Empower-TMS-Video_Final
.jpg/jcr:content/image%20(17).jpg)
Empower TMS Video_Final
Request-form
